Literature DB >> 7067964

Inferior vena cava stenosis and Budd--Chiari syndrome in a woman taking oral contraceptives.

G Lalonde, G Théoret, P Daloze, P Bettez, S S Katz.   

Abstract

A young white woman who had been taking oral contraceptives for 8 yr presented with the Budd--Chiari syndrome. Stenosis of the hepatic segment of her inferior vena cava was observed and surgical correction was attempted, but she died of intravascular coagulation during the procedure. Postmortem examination showed myxoid intimal proliferation involving the hepatic, portal and femoral veins, and the inferior vena cava at the level of the stenosis. The literature describing inferior vena caval lesions causing the Budd--Chiari syndrome is reviewed, and the possible role of contraceptive steroids in the present patient is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7067964

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  4 in total

1.  Budd-Chiari syndrome associated with oral contraceptive steroids. Review of treatment of 47 cases.

Authors:  J H Lewis; H L Tice; H J Zimmerman
Journal:  Dig Dis Sci       Date:  1983-08       Impact factor: 3.199

2.  Budd-Chiari syndrome in a young patient with anticardiolipin antibodies: need for prolonged anticoagulant treatment.

Authors:  R J Ouwendijk; J C Koster; J H Wilson; J Stibbe; J S Lameris; W Visser; J P Benhamou
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

Review 3.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

4.  A case of Budd-Chiari syndrome with high antiphospholipid antibody in a patient with systemic lupus erythematosus.

Authors:  Y Y Yun; K A Yoh; H I Yang; S H Park; S H Lee; C S Cho; H Y Kim
Journal:  Korean J Intern Med       Date:  1996-01       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.